Dermadry is recognized by the International Hyperhidrosis Society
. Our device is FDA cleared, and has an active medical license from both Health Canada and the Australian Therapeutic Goods Administration. Additionally, our Dermadry Total device has obtained the seal of approval from the Canadian Podiatric Medical Association (CPMA).
Our device allows patients to treat excessive sweating of the hands, feet, and underarms from the comfort of their home. Our device is designed with simplicity, efficiency, and safety in mind, allowing patients to regain freedom and break free from their excessive sweating, by customizing their treatment schedule to fit their lifestyle. Treatment sessions are 15 minutes (underarms) and 20 minutes (for hands and feet) and can provide up to 6 weeks of dryness at a time.
Excessive sweating is reported to affect at least 5% of the global population. Our mission is to raise awareness of a misunderstood, under-reported and under-diagnosed condition and make iontophoresis more known and accessible to all hyperhidrosis patients.